The Cooper Companies, Inc. (NASDAQ:COO) Given Consensus Recommendation of “Moderate Buy” by Brokerages

The Cooper Companies, Inc. (NASDAQ:COOGet Free Report) has received an average recommendation of “Moderate Buy” from the twelve brokerages that are presently covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $117.00.

Several research analysts have recently weighed in on COO shares. Wells Fargo & Company lifted their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Morgan Stanley dropped their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Citigroup reduced their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Finally, StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th.

Read Our Latest Stock Report on COO

Cooper Companies Price Performance

NASDAQ COO opened at $96.55 on Monday. Cooper Companies has a 1 year low of $84.76 and a 1 year high of $112.38. The business’s fifty day moving average is $95.79 and its two-hundred day moving average is $99.71. The stock has a market capitalization of $19.27 billion, a P/E ratio of 49.51, a P/E/G ratio of 2.48 and a beta of 0.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COOGet Free Report) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.87 earnings per share. On average, research analysts forecast that Cooper Companies will post 3.98 earnings per share for the current fiscal year.

Institutional Trading of Cooper Companies

Institutional investors and hedge funds have recently modified their holdings of the company. Ashton Thomas Securities LLC acquired a new stake in Cooper Companies during the third quarter worth $25,000. Byrne Asset Management LLC bought a new position in shares of Cooper Companies during the 4th quarter worth about $33,000. Covestor Ltd boosted its position in shares of Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 200 shares in the last quarter. Brown Brothers Harriman & Co. increased its stake in Cooper Companies by 191.0% in the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after acquiring an additional 275 shares during the period. Finally, West Financial Advisors LLC acquired a new position in Cooper Companies in the fourth quarter worth about $49,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Company Profile

(Get Free Report

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

See Also

Analyst Recommendations for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.